Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128915 · ClinicalTrials.gov registry record · Phase 4
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
A Phase 4 study of Aging, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06128915: Recruiting Phase 4 study of Aging, sponsored by State University of New York at Buffalo.
NCT06128915 is a Phase 4 study of Aging that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 60 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06128915, a Phase 4 study of Aging, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.
Primary Outcome
OPH will be determined by measuring the percentage of S. pneumoniae bacteria killed in vitro by neutrophils from donors
Conditions Studied
Interventions
- OTHER vaccine
Study Locations (1)
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-08 |
| Est. Completion | 2026-05-31 |
| Phase | Phase 4 |
What NCT06128915 shows while recruiting
NCT06128915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which vaccine is the first listed.
NCT06128915 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06128915 about?
NCT06128915 is a clinical study titled "The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses". This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.
What is the current status of trial NCT06128915?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-01-08. Estimated completion is 2026-05-31.
What conditions does trial NCT06128915 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT06128915?
The interventions under investigation include: vaccine (OTHER).
Who is sponsoring clinical trial NCT06128915?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06128915 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06128915's enrollment target sits among peer trials
60 137th of 262 higher than 120 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
RECRUITING · Phase 4
-
Role of Menopause in Thermoregulation
RECRUITING · Phase 4
-
Aging, Beta Blockers, and Thermoregulatory Responses
RECRUITING · Phase 4
-
The Effect of NAD Supplementation on Brain Vascular Health in Aging
RECRUITING · Phase 4
-
Skin Barrier Function and Inflammation in Aging: The BIA Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI